WuXi XDC Cayman Inc (hkse:02268) Share Price

Company Profile

Business description
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Contact
No. 11 Xinhui Ring Road
Xinwu
Jiangsu
Wuxi
CHN
https://www.wuxixdc.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
1,496

Recommended

The market is underestimating the clear path to profitability.

Roy van Keulen | 14 January 2025

Shares drop 17% after guidance is revised but we still see value.

Shane Ponraj | 09 January 2025

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Joseph Taylor | 09 January 2025

Index	Last price	Change	% Change
All Ordinaries	8,456.80	15.00	-0.18%
CAC 40	7,427.12	3.45	0.05%
DAX 40	20,363.91	92.58	0.46%
Dow JONES (US)	42,518.28	221.16	0.52%
FTSE 100	8,258.71	57.17	0.70%
HKSE	19,286.07	66.29	0.34%
NASDAQ	19,044.39	43.71	-0.23%
Nikkei 225	38,444.58	29.72	-0.08%
NZX 50 Index	12,943.57	59.19	0.46%
S&P 500	5,842.91	6.69	0.11%
S&P/ASX 200	8,213.30	17.70	-0.22%
SSE Composite Index	3,227.12	13.82	-0.43%